Inmune Bio, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boca Raton, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Inmune Bio, Inc. has filed 587 SEC EDGAR filings since 13 Jul 2017

SEC filing history

Showing 51-75 of 587 matching filings.

Per page
25
Current page
3
8-K File 001-38793

CURRENT REPORT

Filing date
07 Aug 2025
Reporting date
04 Aug 2025
Next action
Verify source filing
10-Q File 001-38793

QUARTERLY REPORT

Filing date
07 Aug 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
29 Jul 2025
Reporting date
29 Jul 2025
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
25 Jul 2025
Reporting date
24 Jul 2025
Next action
Verify source filing
SCHEDULE 13G File 005-90859

SCHEDULE 13G filing

Filing date
02 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
30 Jun 2025
Reporting date
27 Jun 2025
Next action
Verify source filing
424B5 File 333-279036

PROSPECTUS SUPPLEMENT

Filing date
30 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
30 Jun 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
26 Jun 2025
Reporting date
26 Jun 2025
Next action
Verify source filing
S-8 File 333-288058

REGISTRATION STATEMENT

Filing date
16 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-288057

REGISTRATION STATEMENT

Filing date
16 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
10 Jun 2025
Reporting date
10 Jun 2025
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
14 May 2025
Reporting date
14 May 2025
Next action
Verify source filing
DEFR14A File 001-38793

REVISED DEFINITIVE PROXY STATEMENT

Filing date
09 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
08 May 2025
Reporting date
08 May 2025
Next action
Verify source filing
10-Q File 001-38793

QUARTERLY REPORT

Filing date
08 May 2025
Reporting date
31 Mar 2025
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
07 May 2025
Reporting date
07 May 2025
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
05 May 2025
Reporting date
05 May 2025
Next action
Verify source filing
DEFA14A File 001-38793

DEFINITIVE ADDITIONAL MATERIALS

Filing date
25 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38793

PROXY STATEMENT

Filing date
21 Apr 2025
Reporting date
28 May 2025
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
16 Apr 2025
Reporting date
16 Apr 2025
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
14 Apr 2025
Reporting date
14 Apr 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-90859

SCHEDULE 13G/A filing

Filing date
10 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
09 Apr 2025
Reporting date
03 Apr 2025
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
01 Apr 2025
Reporting date
01 Apr 2025
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .